Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Donghai Securities is a comprehensive financial services provider based in China, primarily engaged in securities brokerage, investment banking, and asset management. While the company is not a biotechnology or pharmaceutical firm, it plays a role in the healthcare sector as a financial intermediary, providing underwriting, advisory, and investment services to life science and healthcare companies. Its business segments include securities trading, investment consulting, financial advisory, and proprietary trading. The firm is headquartered in Changzhou and maintains a significant presence across major Chinese financial hubs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Donghai Securities.